From a healthcare fraud enforcement perspective, 2016 was nothing short of a dynamic year.
It was punctuated by the arrival of several important trends within the addiction treatment, post-acute care and compound pharmaceutical industries.
It also featured a Supreme Court ruling on a False Claims Act legal theory, and a changing enforcement landscape in the aftermath of the Yates memo.
As 2016 comes to a close, let's look back at some of the fraud trends that emerged—or in some cases intensified—over the last 12 months.